take a closer look, page-18

george,

as a long term shareholder i think you really need to concentrate on the progress the business is making and forget about the shareprice for a while.

as rgold has pointed out, 12 months ago LUM had an obligation to Durst in the US that was killing them, they had no revenues, no viable business plan - they were a shambles.

now through the vertigo acquisition LUM have ongoing contracts, good revenues, a modest cash burn, a real business plan and a ridiculous market cap of around $3 million.

i think it could be beneficial for you to read the quarterly reports of some other tech/bio tech companies and compare their revenues, market caps to LUM. i have done so with dozens of speculative companies and found that even at this early stage of the Vertigo acquisition LUM compares well with companies that have market caps as high as $60 mill.

in time as the Vertigo earnings grow, LUM move into profitability the sp will take care of itself. and with such a low market cap there is always the chance that ONE really good announcement could come at any time and we could see anything up to a 200% gain in one day. Imagine for example that Vertigo manage to get an advertiser on the Marmara Hotel sign in Turkey. That is quite plausable, traders would be all over LUM like bees to honey.

There is still very low script out there for LUM for such a cheap company which is one of the biggest things this company has going for it. If it had 2 billion shares on issue at a price of 1c it would probably just be a scrap stock forever but there is still good potential that a viable business can be salvaged out of this.